Cogent Net Income from 2010 to 2026
| COGT Stock | USD 36.76 0.44 1.18% |
Net Loss | First Reported 2015-09-30 | Previous Quarter -73.5 M | Current Value -80.9 M | Quarterly Volatility 24.9 M |
Check Cogent Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.3 M, Interest Expense of 4.8 M or Selling General Administrative of 52.3 M, as well as many indicators such as Price To Sales Ratio of 35.83, Dividend Yield of 0.0 or PTB Ratio of 3.58. Cogent financial statements analysis is a perfect complement when working with Cogent Biosciences Valuation or Volatility modules.
Cogent | Net Income | Build AI portfolio with Cogent Stock |
The evolution of Net Income for Cogent Biosciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Cogent Biosciences compares to historical norms and industry peers.
Latest Cogent Biosciences' Net Income Growth Pattern
Below is the plot of the Net Income of Cogent Biosciences over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cogent Biosciences financial statement analysis. It represents the amount of money remaining after all of Cogent Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cogent Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cogent Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (255.86 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cogent Net Income Regression Statistics
| Arithmetic Mean | (77,941,091) | |
| Coefficient Of Variation | (116.47) | |
| Mean Deviation | 75,322,246 | |
| Median | (30,273,000) | |
| Standard Deviation | 90,780,212 | |
| Sample Variance | 8241T | |
| Range | 249.3M | |
| R-Value | (0.89) | |
| Mean Square Error | 1871.6T | |
| R-Squared | 0.79 | |
| Slope | (15,949,008) | |
| Total Sum of Squares | 131856.7T |
Cogent Net Income History
Other Fundumenentals of Cogent Biosciences
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cogent Biosciences Net Income component correlations
About Cogent Biosciences Financial Statements
Cogent Biosciences shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although Cogent Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Cogent Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cogent Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -230.3 M | -218.8 M | |
| Net Loss | -230.3 M | -218.8 M | |
| Net Loss | -126.2 M | -132.5 M | |
| Net Loss | (2.22) | (2.33) | |
| Net Income Per E B T | 0.86 | 0.76 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cogent Stock Analysis
When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.